132 related articles for article (PubMed ID: 3212388)
1. Synergistic growth-inhibitory activity of tumour necrosis factor and alpha interferon. Contribution to the monocyte-derived cytostatic activity towards human leukaemia K562 cells.
Nissen-Meyer J; Austgulen R; Espevik T
Scand J Immunol; 1988 Nov; 28(5):627-37. PubMed ID: 3212388
[TBL] [Abstract][Full Text] [Related]
2. Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition.
Austgulen R; Nissen-Meyer J; Degré M; Espevik T
Scand J Immunol; 1987 Aug; 26(2):175-85. PubMed ID: 3114873
[TBL] [Abstract][Full Text] [Related]
3. Effect of antisera against recombinant tumor necrosis factor and the monocyte-derived cytotoxin(s) on monocyte-mediated killing of various tumor cells.
Nissen-Meyer J; Espevik T
Cell Immunol; 1987 Oct; 109(2):384-96. PubMed ID: 3478143
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
Nissen-Meyer J; Austgulen R; Espevik T
Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
[TBL] [Abstract][Full Text] [Related]
5. Antileukemic effect of recombinant tumor necrosis factor alpha in vitro and its modulation by alpha and gamma interferons.
Beran M; McCredie KB; Keating MJ; Gutterman JU
Blood; 1988 Aug; 72(2):728-38. PubMed ID: 3135864
[TBL] [Abstract][Full Text] [Related]
6. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
7. Differential cytostatic activity of monocyte-derived cytokines against human melanoma cells.
te Velde AA; vd Wiel-v Kemenade E; Figdor CG
Int J Cancer; 1992 Mar; 50(5):746-51. PubMed ID: 1544709
[TBL] [Abstract][Full Text] [Related]
8. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
[TBL] [Abstract][Full Text] [Related]
9. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
10. A physico-chemical comparison of the monocyte-derived fibroblast growth factor and the tumour necrosis factor.
Austgulen R; Nissen-Meyer J
APMIS; 1988 Apr; 96(4):352-6. PubMed ID: 3370158
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
12. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
Espevik T; Nissen-Meyer J
J Immunol Methods; 1986 Dec; 95(1):99-105. PubMed ID: 3782828
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-like activity on paraformaldehyde-fixed monocyte monolayers.
Espevik T; Nissen-Meyer J
Immunology; 1987 Aug; 61(4):443-8. PubMed ID: 3443451
[TBL] [Abstract][Full Text] [Related]
14. Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell lines.
Beran M; Andersson BS; Kelleher P; Whalen K; McCredie K; Gutterman J
Blood; 1987 Mar; 69(3):721-6. PubMed ID: 3028534
[TBL] [Abstract][Full Text] [Related]
15. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
16. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
[TBL] [Abstract][Full Text] [Related]
17. Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response.
Aggarwal BB; Eessalu TE
J Biol Chem; 1987 Jul; 262(21):10000-7. PubMed ID: 2440858
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth-stimulatory activity released from human monocytes. The contribution of tumour necrosis factor.
Austgulen R; Espevik T; Nissen-Meyer J
Scand J Immunol; 1987 Dec; 26(6):621-9. PubMed ID: 3423739
[TBL] [Abstract][Full Text] [Related]
19. Modulation of monocyte antigen-presenting capacity by tumour necrosis factor-alpha (TNF): opposing effects of exogenous TNF before and after an antigen pulse and the role of TNF gene activation in monocytes.
Kowalczyk D; Mytar B; Jasiński M; Pryjma J; Zembala M
Immunol Lett; 1995 Jan; 44(1):51-7. PubMed ID: 7721344
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
